Your post seems about what I would expect. However this statement is not like the others and is wrong. How was this gleaned from the PR about the LH p2 trial:
“The most vital symptoms showed no statistical improvement…”
I believe this deserves explaining. Are we saying the 6 symptoms not helped are the most important or just the fact that the trial was exploratory and therefore statistical improvement was not built into it? If the former, how’d you determine vital? If the latter, then isn’t “vital” an unnecessary qualifier?
In other words are you saying the clinical outcomes were bad or that it’s all just fluff?
Market Data 
Markets 
AI
